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Summary 
Toxoplasma gondii is a zoonotic parasite which, depending on the geographical location, can 
infect between 10 to 90% of humans. Infection during pregnancy may result in congenital 
toxoplasmosis. The effects on the fetus vary depending on the stage of gestation in which 
primary maternal infection arises. A large body of research has focused on understanding 
immune response to toxoplasmosis, although few studies have addressed how it is affected by 
pregnancy or the pathological consequences of infection at the maternal-fetal interface. There 
is a lack of knowledge about how maternal immune cells, specifically macrophages are 
modulated during infection and the resulting consequences for parasite control and pathology. 
Herein, we discuss the potential of T. gondii infection to affect the maternal-fetal interface 
and the potential of pregnancy to disrupt maternal immunity to T. gondii infection. 
 
1. Introduction 
Toxoplasma gondii is a protozoan parasite with a global distribution. It is an important 
pathogen of humans and their livestock. In humans, it can cause abortion or a spectrum of 
clinical diseases dependent on the parasite isolate, the host immune status and whether 
infection is acquired post-natally or in utero 
1,2
. T. gondii infection causes substantial losses 
due to abortion in livestock (including sheep, goats and pigs) and the ability of livestock to 
act as reservoir of disease is a public health risk 
3
. Limited genetic variability has been 
recognised in T. gondii strains isolated from Europe and North America for some time. The 
vast majority of T. gondii isolates characterised to date can be classified as Type I, II and III 
4
. Each of these canonical T. gondii lineages have different patterns of virulence as 
empirically determined in mice and supported by restriction length polymorphisms, 
isoenzyme analysis, large-scale genome sequencing and transcriptomics. However, more 
recent analyses of T. gondii isolates from diverse geographical regions, most notably South 
America has revealed a greater genetic diversity with at least 15 haplogroups that fall into 6 
major clades 
2,4-7
. The rapidly-replicating tachyzoite life cycle stage predominates for around 
10-14 days post infection before differentiating into bradyzoites, which replicate more slowly 
and form cysts in tissues throughout the body 
8
. Tissue cysts are long-lived and are generally 
not considered responsible for significant disease, although associations with seropositivity 
and some neuropsychiatric diseases have now been recognised 
9
. Infection of immune-
competent adults with these canonical strains of T. gondii has been generally considered self-
resolving. This is largely due to a robust systemic immune response to T. gondii that controls, 
but does not eliminate infection 
10
. However, tissue cysts are assumed to rupture from time to 
time and in people with immunodeficiencies disease reactivation occurs, causing neurological 
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and sometimes ocular or systemic disease 
8
. T. gondii can also cause congenital disease and 
abortion, almost exclusively in women infected for the first time during pregnancy 
11
. 
Congenitally infected individuals are also at risk of repeated disease reactivation, mostly 
evident through ocular and neurological disease, though the reason for this remains to be 
determined 
12
. It is now recognised that certain lineages and recombinant strains of T. gondii 
that are common in South America are responsible for severe disease in humans even when 
acquired as immune-competent 
5,13
.  
 
2. Immune response during T. gondii infection  
The major findings concerning systemic T. gondii immune response have come from 
experimental murine models, and much of this has been corroborated through clinical studies 
and in vitro studies
8,14
. Challenges exist in extrapolating the data between studies as 
differences including the mouse strain, parasite strain and life-cycle stage used to infect, dose 
of inoculum and route of infection often varies
15
. It is not usually ethically possible to test if 
the murine studies can be translated into humans as this would involve deliberately infecting 
humans. Nonetheless a consensus of the sequence of immunological events after infection 
emerges 
1,14
. 
 
Following oral infection, enterocytes are the first line of defense against T. gondii, since this 
parasite is acquired mainly via oral ingestion in mouse, human and other intermediate hosts. 
Parasites disseminate within the lymphatic and circulatory systems and spread throughout the 
body. There is evidence that by invading dendritic cells (DCs) and macrophages, previously 
recruited by the chemokines secreted by infected enterocytes, T. gondii is able to cross 
endothelial barriers, thus allowing entry into sites such as the brain 
8,15
. Neutrophils, DCs, 
macrophages and natural killer (NK) cells, have been shown to play an important role in the 
innate immune response to T. gondii by controlling parasite multiplication 
10
. During acute T. 
gondii infection chemokines, belonging to the CC and CXC chemokine superfamilies and 
their receptors have an important role in the recruitment of NK, DCs, monocytes, neutrophils 
and in the induction of T helper (Th)1 and CD8+ cytotoxic T cells, as reviewed elsewhere 
16
. 
The process of neutrophil recruitment and control of parasite numbers during the initial 
stages of T. gondii infection has been shown to be dependent on interleukin (IL)-17 signaling 
17
. 
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T. gondii has a unique cyclophilin 18 with the ability to bind C-C chemokine receptor type 5 
(CCR5) and a number of ligands for toll-like receptors (TLRs) including, 
glycosylphosphatidylinositol-anchored proteins (GIPLs), heat shock protein 70 (HSP70) and 
profilin, which interact with TLR-2, 4 and 11 
10,18
. This results in induction of many 
cytokines including IL-12 produced by parasite-infected DCs, macrophages and neutrophils. 
Interferon (IFN)-γ acts in a synergic way with tumor necrosis factor (TNF)-α, inducing nitric 
oxide (NO) production by macrophages. NO can inhibit essential parasite mitochondrial and 
nuclear enzymes, thereby killing tachyzoites or inducing their conversion to the bradyzoite 
stage 
19
. IFN-γ also controls: (1) generation of reactive oxygen intermediates with 
toxoplasmacidal activity in human infected macrophages; (2) iron deprivation within T. 
gondii infected enterocytes, leading to inhibition of parasite replication; (3) tryptophan 
starvation through indoleamine-2,3-dioxygenase pathway, inhibiting T. gondii growth, and 
(4) activation of the p47 GTPases that bind to subcellular membranes, such as endoplasmic 
reticulum and Golgi bodies, thereby mediating disruption of the parasitophorous vacuole by 
exposing the parasite to the cytosol 
20
. However, an excessive Th1 response leads to tissue 
damage, which may lead to the development of pathology. Notably, both IL-4 deficient and 
IL-10 deficient mice have reduced survival following infection with T. gondii relative to 
wild-type mice as a likely consequence of reduced Treg and Th2 cell 
15,21,22
. Thus, the ability 
of the host to balance this response by maximizing pathogen clearance and minimizing 
immunopathology 
19
 (Figure 1). 
 
3. Congenital Toxoplasmosis 
Congenital toxoplasmosis constitutes a major problem for human health, leading to severe 
implications for those affected from fetus to adulthood 
1,8
. However, it is known that the 
relative risk to the fetus depends on various factors, such as the mother’s immunological 
status and genotype, parasite genotype and virulence as well as the gestational period when 
infection is acquired 
1,4,8
. Other disease determinants include the infectious dose, whether 
infection is initiated with oocysts or tissue cysts or the occurrence of co-infections 
1,4
.  
 
Primary T. gondii infection in the first trimester is associated with a high risk of several 
adverse pregnancy outcomes including abortion, stillbirth and premature birth, but with a low 
risk of congenital transmission 
11
. If pregnancy results in a viable child, T. gondii infection 
may cause a wide range of clinical manifestations, such as neonatal malformations that are 
severe enough to ultimately result in blindness, chorioretinitis, mental retardation, heart and 
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brain defects, permanent neurological damage and death 
11
. If transmission occurs at later 
stages of pregnancy, abortion is unlikely, but the risk of congenital infection is increased 
(Figure 2) 
23
. Under these circumstances, infected newborns will often be asymptomatic at 
birth, but essentially will all develop chorioretinitis later in life 
1,11,24
. If infection occurs prior 
to pregnancy, the risk to the unborn child is extremely low, even if the mother is re-exposed 
to another infection. However, there is a growing body of literature which demonstrates, in a 
small number of cases, that maternal disease reactivation can occur during pregnancy and 
sometimes result in adverse effects on the developing fetus 
1,11,25,26
,
27
. In addition, other cases 
have been reported in which pregnant women with immune suppression due, for example, to 
HIV infection, have resulted in congenital toxoplasmosis 
28,29
. Furthermore, several studies 
monitoring females with previously acquired T. gondii infection through pregnancy found 
maternal disease reactivation at the ocular site 
27,30
. The cysts stages are presumed to be the 
source of disease reactivation in all of the above scenarios. Altogether, these data suggest that 
in the vast majority of cases, a previous maternal infection protects against congenital 
transmission, even when exposed to a heterologous challenge. However, hormonal-induced 
alteration of systemic immunity occurs in some pregnancies and can result in disease 
activation and, occasionally, in vertical transmission (Figure 2) 
1,25,26,31  
 
4. Effect of T. gondii infection on implantation 
Healthy pregnancy is highly dependent on appropriate immune responses from coitus to post-
partum
32,33
. Seminal plasma released during coitus contains a variety of immunologically 
active components including transforming growth factor (TGF)-, CXCL8, IFN- and 
prostaglandin E 
34,35
. These mediators are responsible for changes in local gene expression, 
recruitment of monocytes, DCs, NK cells, T cells and expansion of Treg cells and, thus, sets 
the immunological context for the first encounter of the maternal immune system with 
paternal antigens 
33,35,36
. As the blastocyst undergoes implantation, macrophages are required 
to clear apoptotic maternal uterine cells 
37-39
. There is now evidence of progressive maternal 
immune regulation at the maternal-fetal interface comprising the fetus-derived placenta and 
the decidua 
33,40
. The development of a decidua is dependent on progesterone and is crucial 
for implantation 
41,42
. The blastocyst breaches the uterine epithelium, an event that is 
accompanied by inflammation and infiltration of decidual leukocytes, including NK cells, 
macrophages, dendritic cells and T cells 
33
. The success of implantation is dependent on the 
expression of a number of cytokines and chemokines including leukemia inhibitory factor 
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(LIF), IL-6, IL-15, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-33, 
CXCL8, CXCL1, MIP-1α and RANTES and activation of signalling pathways like JAK-
STAT, MAPK, Notch, Smad and PI3K 
33,43,44
. Macrophages, decidual NK cells (dNK), 
decidual dendritic cells (dDC) and other leukocytes are present in the endometrium at this 
stage and have been demonstrated to play important roles during implantation and, 
subsequently, promote tolerance to the fetus 
33,36,38,45
. Treg cells expand in peripheral blood 
and lymphoid organs in the preimplantation period, migrating and, subsequently, 
accumulating in the decidual tissue 
46
. Besides their importance in ovarian homeostasis and 
ovulation, these cells have a central role in implantation, preventing maternal anti-fetal 
responses, and are thus determinant in the maintenance of pregnancy 
33,46
.  
 
The potential for T. gondii to disrupt these early events in pregnancy has scarcely been 
studied. Nevertheless, in murine models, chronic T. gondii infection has been shown to 
increase reproductive failure 
47
. These alterations have been attributed to tissue cysts of T. 
gondii in various organs, especially in the brain, potentially causing damage in the 
hypothalamic–pituitary–gonadal axis and leading to alteration in the female estrus cycle 47. 
However, in other infection models, such as for Trypanosoma cruzi, inhibition of 
implantation and cell division has also been described 
47
. Nevertheless, T. gondii acute 
infection induces transient changes in systemic expression of many immune mediators, which 
in theory have the potential to antagonise normal immune changes during pregnancy (Figure 
1) 
8,10,17,48-50
.  
 
5. Effect of T. gondii infection on the developing placenta, decidua and fetus 
As pregnancy progresses there are a number of alterations in the maternal immune system, 
which facilitate fetoplacental development and prevent fetal rejection 
32
. Successful healthy 
pregnancy is highly dependent on specific regulation and balance of maternal immune 
responses within the decidua and placenta. This immune regulation enables growth and 
provides protection of the semi-allogeneic fetus, expressing paternal major histocompatibility 
antigens from maternal immune rejection 
51,52
. Dysfunction of this immune regulation by 
extrinsic factors, as in the case of infection, compromises pregnancy maintenance leading to 
adverse gestational outcomes  
53
.  
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T. gondii infection can have profound effects on the systemic maternal cellular immune 
responses and affects normal immune mechanisms at the maternal-fetal interface and can thus 
influence pregnancy outcome 
2
. T. gondii strains with different virulence are known to infect 
decidual immune cell populations and the placenta, a prime anatomical location to alter 
immune responses at the maternal-fetal interface 
48,54,55
. On the other hand, the 
immunomodulation during pregnancy may contribute to the development of an environment 
(dominated by Th2 and Treg cells) that facilitates the escape of T. gondii from the immune 
response, leading to increased maternal pathology or an increased likelihood of congenital 
transmission 
56
.  
 
6. The placenta and T. gondii infection 
Trophoblasts are epithelial-type cells that constitute the fetal placenta. Cytotrophoblasts act as 
stem cells for other trophoblast cell types: the syncytiotrophoblast and extravillous 
trophoblasts. The syncytiotrophoblast forms a multinucleated cell layer that is directly in 
contact with maternal blood, allowing an intimate interaction between mother and fetus. 
Extravillous trophoblasts have the ability to invade maternal tissues. These cells essentially 
function to protect the fetus from harmful substances, while facilitating the passage of 
nutrients and factors important for fetal development. The immune response within the 
placenta provides protection from infection and contributes to maternal tissue remodeling, 
which is fundamental for fetus development 
1,57
.  
 
Human and experimental animal models have shown that trophoblasts are a component of the 
innate immune system, since they recognize pathogens, produce chemokines and cytokines, 
which influence the differentiation and migration of macrophages, NK, Treg and DCs at the 
decidua 
58-60
. Trophoblasts are responsible for the production of a variety of anti-
inflammatory mediators, including TGF-β, IL-10 and Fas ligand 61. However, in some 
situations, trophoblasts may also initiate signals that promote fetal rejection 
62,63
.  For 
example, studies have demonstrated that activation of TLR3 in the trophoblast, by Poly[I:C], 
a synthetic analog of viral dsRNA induces preterm delivery in mice. In vitro studies 
demonstrate that Poly[I:C] stimulation of both mouse primary trophoblast or human 
trophoblast induces a range of cytokines and chemokines (including MCP-1, RANTES, IL-6 
and IL-12), supporting the idea that these cells function as an immune regulators and 
influence the differentiation and migration of immune cells 
62
. Although T. gondii does not 
have TLR3 ligands, it does have ligands that can activate TLR2,4 and 11 and these could 
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have similar effects
8
. Indeed, infection may alter crosstalk, inducing TLR-mediated 
trophoblast inflammatory or apoptotic responses, influencing the recruited and resident 
maternal immune cells. In extreme cases, as during T. gondii infection, these cells shift from 
a protective to an aggressive phenotype promoting fetal rejection 
55,60
. Notably in this respect, 
administration of the TLR4 ligand, lipopolysaccharide (LPS) to pregnant mice induces 
abortion through the induction of TNF- and nitric oxide synthase 64.  
 
Trophoblasts are also inextricably linked to parasite transmission to the fetus, since they are 
strategically located between maternal and fetal blood circulation systems and are efficiently 
infected with T. gondii 
54
. In vitro studies using Bewo cells, a human trophoblast cell line, 
have shown that trophoblast susceptibility to T. gondii increases in response to high 
concentrations of macrophage inhibitory factor (MIF)
65
. In contrast, treatment of Bewo cells 
with IL-10 or TGF- promoted T. gondii proliferation. In contrast to parallel experiments 
performed in HELA cells, the addition of IFN-γ to Bewo cells did not curtail T. gondii 
proliferation unless IL-10 or TGF- were neutralised with specific antibodies 66. Thus, IFN-, 
was not able to control T. gondii proliferation in Bewo cells, contrary to expected, suggesting 
that this cytokine has different activities at the maternal-fetal interface, depending on other 
host factors 
66
.  
 
Recently, ex-vivo experiments, using primary human trophoblasts isolated from placentas of 
both the second and third trimesters, have shown that syncytiotrophoblast cells are able to 
restrict T. gondii attachment and intracellular parasite replication in an IFN-γ-independent 
manner 
67
. The T regulatory chemoattractant CCL22 expression has been associated with 
miscarriage 
68
, and levels of this ligand were increased in primary human placental cells 
isolated from full-term placentas in response to T. gondii infection 
67
. It has also been shown, 
that earlier in human pregnancy, using mid-gestation chorionic villous explants, trophoblasts 
was also able to restrict T. gondii attachment and increase CCL22 production 
67
. Increased 
trophoblast apoptosis and necrosis occurring after T. gondii infection is dependent on 
inflammatory cytokines, such as IFN, which can be a factor in determining pregnancy 
outcomes in women infected by this parasite 
69
. In contrast, IL-10 is able to reduce T. gondii–
infected trophoblast apoptosis levels 
69
. If trophoblast invasion is excessive, which occurs 
during a T. gondii infection, IFN-γ has a dual function, thereby limiting parasite replication 
and promoting its removal 
40,66
. Adhesion of infected monocytes to trophoblasts could also 
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promote placental and fetal infection. However, trophoblasts are able to modulate monocyte 
activity controlling T. gondii infection, thus promoting pregnancy maintenance
70
. Overall, the 
interaction between trophoblast cells and maternal-fetal immune cells, specifically 
macrophages are likely to determine T. gondii survival and putative vertical transmission 
65,66,70,71
.   
 
7. The decidua and T. gondii infection 
The decidua results from proliferation and differentiation of stromal endometrial cells into 
decidual stromal cells (DSC) by a process called decidualization. These cells are important 
for embryo implantation, placentation and modulation of local immune cell functions that are 
essential for maternal/fetal tolerance and protection against infections. DSC are activated by 
TLR signalling, produce growth factors, such as G-CSF, cytokines including IL-6 and TNFα, 
as well as chemokines, like IL-8, CXCL1, and possess the chemokine receptors CXCR4. 
These chemokines induce the recruitment of T cells, monocytes and peripheral NK, 
modulating the activation profile at the decidua 
72,73
. Depending on the decidua environment, 
DSC can contribute to a successful pregnancy or miscarriage
74,75
. T. gondii tropism is not 
clearly understood, although the decidua/trophoblasts interface is highly vulnerable to 
infection after parasite dissemination through maternal leukocytes 
54
. As yet, there is no 
description regarding the interplay between DSC and T. gondii infection. 
 
8. Decidual immune cells and T. gondii infection 
The decidua is a highly dynamic immunological tissue composed of different maternal 
immune cell types, and is also modulated by placental-derived factors 
51,76
. Recently, murine 
studies have suggested an important role for CCR5 and RANTES in abortion caused by T. 
gondii infection
77
. In fact, it is suggested that embryo loss results from alteration of decidual 
and trophoblastic function, induced by recruitment of macrophages, DCs and T cells in 
response to increased expression levels of CCR5 and RANTES, in implantation units from T. 
gondii infected mice
77
. Quantitative proteomic analysis of T. gondii-infected human decidual 
immune cells has revealed differential expression of protein levels involved in immune 
tolerance, fetal intrauterine growth and trophoblast invasion, essential biological processes 
during pregnancy. For instance, decreased levels of IL-1 and increased levels of Granzyme 
A and CCAAT/enhancer-binding protein  (C/EBPβ) expression were found in T. gondii-
infected decidual immune cells compared with uninfected ones 
78
. Decreased IL-1 levels 
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during T. gondii infection would affect the immune-balance at the maternal-fetal interface 
and restrict decidualization, placenta development and development of the fetus
78
. Increased 
granzyme A levels is indicative of increased NK cells and cytotoxic T cells and again could 
affect decidualization and fetus development 
78. C/EBPβ is involved in ERK1/2 signalling 
during decidualization in human and mice, and in macrophage activation 
79,80
. These 
observations suggest that, by interfering with the related-pathways to decidual immune 
responses, T. gondii infection can negatively affect pregnancy outcome 
78
. 
 
8.1. Decidual NK cells and T. gondii infection 
The NK cells present at the uterine mucosa and decidua, referred to as dNK cells, constitute 
the main leukocyte cell population during implantation and early pregnancy. These cells 
account for 70% of all decidual leukocytes and are functionally and phenotypically different 
from blood-circulating NK cells 
81
. Specifically, the majority of dNK cells are highly 
granulated and characterized as CD56
bright
/CD16
-
 non-cytotoxic NK cells 
38,57,81
. These cells 
interact with the invading trophoblast cells, helping them to migrate and invade, thus 
contributing to the remodeling of decidual spiral arteries into high-conductance blood vessels. 
This allows sufficient blood flow at the maternal-fetal interface, which is crucial for a healthy 
gestation 
38,57,82
. In addition, these cells express angiogenic factors, like vascular endothelial 
growth factor and angiopoietin-2, contributing to the development of placental vascular bed. 
dNK cells also secrete a variety of cytokines, such as TNF-α, TNF-β, IL-10, IL-13 and GM-
CSF 
38
. These immune cells are the main source of IFN-γ, which are essential for 
implantation and early placental progression 
48
. In recent years, several studies have 
demonstrated the ability of T. gondii to modify the immune profile of decidual cells and to 
invade and multiply within uterine dNK cells 
40
. T. gondii infection not only increases IFN-γ 
secretion by dNK cells, but is also associated with higher levels of trophoblast apoptosis, via 
the caspase-3 and caspase-8 mediated pathways 
40
. Additionally, T. gondii infection results in 
the increase of the expression of the human dNK cell-activating receptor (NKG2D), which 
may trigger a higher cytotoxic activity of dNK towards trophoblast cells. It is believed that 
these modifications contribute to abnormal pregnancy outcomes 
83
.  
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8.2. Decidual macrophages during T. gondii infection 
Decidual Macrophages (dM) constitute 20% of the decidual leukocyte population and 
represent the second most abundant immune cell-type population in decidua 
37,76
. dM are 
recruited to the maternal-fetal interface by stromal and trophoblast cells, where they have 
specialized functions, such as decidual homeostasis, placental development and tolerance to 
the semi-allogeneic trophoblast. They also form a major line of defense against invading 
pathogens in the decidua and thus protect the fetus from infection 
37,84,85
. In vitro studies have 
shown that dM differentiation and polarization are regulated by factors produced by 
trophoblasts such as IL-10, supressing IFN -induced Stat1 activation 86. During early 
gestation, dM are also major producers of IL-10 and are able to supress and regulate the 
decidua immune response 
37,38
. dM can decrease the cytolytic activity of dNK cells against 
invading trophoblasts. These leukocytes also play a role in the induction and expansion of 
Treg cells, contributing to the maintenance and support of uterine tissue homeostasis and 
remodelling 
37,38,87
.  
 
dM are able to recognize, phagocytose and eliminate pathogens. In addition, they also 
remove apoptotic cells and cellular debris and, therefore, promote normal fetal development 
and acceptance, preventing tissue damage and fetal rejection 
37,38,87,88
. T. gondii infection of 
human trophoblasts modulates trophoblast-macrophage crosstalk, in order to favor its 
establishment in the host cell 
71
. The polarization of dM is modulated by T. gondii infection, 
but it is still unclear at present how this occurs during human pregnancy 
85
. Human and 
animal studies support the occurrence of both classical and alternative activation in 
macrophages responding to T. gondii 
89
. Macrophages have a variety of activation states, 
being able to adapt their functions to cytokine environmental changes, described as innate 
TLR ligation, classical/M1 or alternative/M2 activation states 
90,91
. Innate macrophages are 
activated after a microbial stimulus, through LPS stimulation or other TLR ligands, 
producing TNF-α, IL-6, IL-12 and NO 92,93. M1 macrophages are antigen-presenting cells, 
activated usually through a combination of LPS and IFN-γ, producing IL-12, IL-23 and 
reactive oxygen species. M2 macrophages can be induced by IL-4, IL-10, IL-13, IL-33, TGF-
β and granulocyte-colony stimulating factor (G-CSF) 87,92 and are important regulators of the 
wound-healing response, tissue homeostasis and adiposity 
93
.  
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M1 and M2 macrophages are often associated with polarised Th1 and Th2 responses, 
respectively. However, M1 and M2 functions can occur either in the presence or absence of T 
cells 
94
. Additionally, during an inflammatory response, M1 and M2 activation profiles are 
present, suggesting a switch between M1 and M2, thereby highlighting the dual role of 
macrophages in initiating and, subsequently, resolving inflammation. Whether this switch 
occurs by local conversion of M1 macrophages to anti-inflammatory M2 cells, or by 
sequential recruitment from distinct precursor cell populations from the blood is currently 
under debate 
95
. Several studies have shown that M2 activation profile includes several stages 
89,96,97
. Thus, while classical macrophage activation can control T. gondii replication through 
induction of iNOS, alternative activation can control parasite replication through induction of 
arginase and depletion of arginine, since this parasite is auxotrophic for arginine 
89,98
. M1 
macrophages induced by a Th1 response in murine models exhibit cytotoxic and 
antimicrobial activities against T. gondii infection. This same response is also associated with 
immunopathology and adverse pregnancy outcomes 
89,99
. In humans, during implantation, 
decidual macrophages consist of a M1/M2 heterogeneous activation profile population. This 
mixed decidual macrophage profile continues to predominate during the first trimester and at 
the beginning of the second trimester of pregnancy, coincident with the vasculature 
remodelling at the uterus. After placental growth, in the final stages of the second trimester, 
decidual macrophages exhibit predominantly an M2 polarized profile, promoting fetus 
maintenance and growth 
85,87,92
.  
 
Several studies have focused on macrophage activation profiles in normal and complicated 
pregnancy. Some of these have associated an imbalance of the macrophage polarization with 
T. gondii intrauterine infection, but failed to determine the context of macrophage polarity 
and the mechanisms promoting their dysregulation at the maternal-fetal interface 
87
. Recently, 
it has been reported that human dM upon T. gondii infection showed upregulated M1 
markers and downregulated M2 macrophage markers concomitantly with a downregulation 
of human leukocyte immunoglobulin-like receptor subfamily B member 4, an important 
factor in immune tolerance and immune regulation during normal pregnancy 
100
. These 
alterations provide a possible explanation for the disruption of pregnancy 
39,100
. Other 
infection models, such as malaria during pregnancy indicates that macrophage accumulation 
in the placenta is a key determinant in the immune pathology associated with this parasite 
101,102
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8.3. Decidual DCs during T. gondii infection 
DCs are antigen-presenting cells priming T cell responses, but dDCs fail to initiate 
immunogenic T cell responses to placental antigens, thus contributing to maternal-fetal 
tolerance 
38,103
. Despite the fewer number of human DCs at the decidua, they play 
determinant roles in normal and pathological pregnancies 
104,105
. In addition, DCs are 
important for materno-fetal tolerance and are also involved in angiogenic responses at the 
maternal-fetal interface 
105
. In normal human decidua, both immature myeloid – identifiable 
by their expression of DC-SIGN (CD209) – and mature myeloid DCs coexist 105. In early 
human pregnancy the presence of DC-SIGN+ cells and dNK clusters indicate that the 
interconnection between these cell subsets is essential in pregnancy maintenance 
106
. In fact, 
dNK cells induce apoptosis in DC-SIGN+ cells, constituting a mechanism of maternal-fetal 
tolerance 
106
. Other models of infection, namely with Coxiella burnetii and Brucella abortus, 
revealed that myeloid dDCs are unable to mature in response to bacterial ligands, such as 
peptidoglycan or LPS, or to produce inflammatory cytokines. This would prevent 
development of effective immunity and favour pathogen multiplication 
107
. However, 
contrary to these observations during bacterial infections, in vitro studies have shown that T. 
gondii-infected human dDCs produced IL-12 which increased the cytotoxicity of dNK cells 
as determined by increased expression of NKG2D and production of IFN-. The presence of 
increased IL-12 and IFN- levels would favor Th1 cells and suppress Th2 cells and thus 
contribute to disruption of pregnancy 
48
. 
 
8.4. Decidual T cells and T. gondii infection 
The relative balance of lymphoid cells, such as Th1, Th2 and Treg cells, present at the 
decidua coordinate macrophage polarization and are vital for successful pregnancy 
108
. In the 
past it was accepted that maternal-fetal immunological balance could be disturbed by T. 
gondii infection by disrupting a pregnancy-induced bias from Th2–type environment 
(associated with IL-4 and IL-10) toward Th1-type environment (associated with IFN-, TNF-
 and IL-12 production), which has been demonstrated to be abortogenic. The discovery of 
new cytokines at the fetal/maternal interface which did not fit the Th1/Th2 paradigm led 
researchers to move away from this dichotomy and explore the Th1/Th2/Th17 and Treg 
paradigm in reproductive immunology 
109
. Th17 cells secrete the cytokines IL-17, IL-21 and 
IL-22, promoting the inflammatory response during pregnancy in T. gondii-infected women 
17
. Treg cells are key players present in the pregnant uterus, contributing to immune 
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regulation, decidualization, maternal immune tolerance and acceptance of the fetus 
38,51,53
. 
Increased Treg cells are positively correlated with the enzyme placental Indoleamine-2,3-
dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) during pregnancy and are linked 
to maternal tolerance 
110,111
. IDO expression is induced by IFN and converts L-tryptophan, 
an essential amino acid during pregnancy, into kynurenine, which favours expansion of Treg 
cells 
111,112
. The importance of these events is evident as reduced levels of kynurenine and 
other downstream metabolites of tryptophan degradation as well as reduced transcripts for 
IDO and TDO are associated with fetal growth restriction 
111
. Furthermore, IDO expression is 
increased in the placenta during acute T. gondii infection at late gestation 
113
. 
 
Recently, a decrease in the ratio Treg/Th17 in T. gondii-infected pregnant mice was reported, 
suggesting a role for this imbalance in T. gondii-induced embryo loss 
114
. During T. gondii 
infection, a decrease in maternal Treg cells has been reported to disrupt fetal tolerance and to 
be associated with pregnancy complications 
115
.  
 
9. Progesterone and T. gondii infection 
Pregnancy-specific factors, such as maternal hormones, are able to modulate the maternal 
immune response and affect the activation of macrophages and lymphocytes 
41,116,117
. 
Progesterone (P4), one of the maternal hormones synthetized in the breast, endometrium, 
brain, ovaries and fetoplacental unit, plays a role during pregnancy by regulating immune 
cells, essential for the maintenance of pregnancy 
41,42,116,118
. Low levels of P4 in pregnant 
women infected with T. gondii provides another potential adverse effect of T. gondii infection 
on pregnancy 
119
. P4 is able to regulate selectively the expression of different genes 
associated with alternative macrophage activation 
92
. In this study, it has been shown that P4 
treatment of murine macrophages selectively reduces transcription of mrc1 (coding for 
mannose receptor), but increases transcription of ym1, demonstrating plasticity in alternative 
macrophage activation with potential significant consequences for pregnancy 
92
. In addition, 
P4 contributes to a local Th2-associated cytokines production by murine fetoplacental tissues 
and recently it has been demonstrated to negatively regulate the differentiation of Th cells 
into Th1 and Th17 
92,120
. Therefore, it is possible that during T. gondii infection, low levels of 
P4 may be implicated in altered macrophage polarization and T cell responses, negatively 
affecting pregnancy. Moreover, during pregnancy, progesterone is able to induce the 
secretion of progesterone-induced blocking factor (PIBF) by progesterone-receptor-positive 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
lymphocytes
121
. PIBF is able to modulate Th1/Th2 balance and contribute to the enhanced 
Th2 profile noted during pregnancy, characterized by increased production of IL-4 and IL-
10
121
. Notably, PIBF can also downregulate NK cytotoxicity favoring gestation progression 
(Figure 1) 
121
. 
 
10. Conclusion 
Successful pregnancy requires a delicate, fine-tuned equilibrium of maternal immune cells at 
the maternal-fetal interface to promote fetal tolerance. The activation of maternal immune 
effector cells by infection dysregulate this equilibrium and can lead to fetal loss or fetal 
infection. There is evidence that T. gondii affects the activation states of numerous cells that 
play pivotal roles at the FMI including dendritic cells, macrophages, NK cells and 
trophoblasts. Importantly, T. gondii disrupts the normal balance of T cell subsets during 
pregnancy favouring the development of Th1 and Th17 cells associated with parasite control 
rather than Th2 and Treg cells that are conducive to normal pregnancy.  In recent years, 
scientific advances have contributed to the understanding of the interactions between fetal 
trophoblasts and maternal immune cells. The effect of T. gondii at the maternal-fetal interface 
is evident in human and murine models, although the mechanisms are not totally clarified. 
There is still a need for further research into the pregnancy-related mechanisms regulating 
dDCs, dNK cells, T cells and dM, upon T. gondii infection which might explain adverse 
pregnancy outcomes and pathological features of congenital toxoplasmosis 
122
. Current pre-
natal and postnatal treatment can reduce the chance of congenital transmission and the 
severity of disease sequela, but not prevent either 
4,123
.  At present, no vaccine exists to 
prevent human disease induced by T. gondii. The only commercially available vaccine is 
ToxoVax
®
 (Intervet B.V.), which is based on live attenuated tachyzoites of T. gondii strain 
S48, but is only for veterinary use 
124
. Greater understanding of the immune response at the 
local maternal-fetal interface could suggest new targets for therapeutic intervention of 
congenital toxoplasmosis. 
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Figure Legends 
 
Figure 1. The immune response developing to acute Toxoplasma gondii infection (green) 
and the immune response changes during pregnancy are mutually antagonistic (red). 
Physiological changes are in grey. (A) T. gondii have a number of pathogen-associated 
molecular patterns (PAMPs; including HSP70, GIPLS and profilin) which can ligate TLRs 
on host cells and a chemokine mimic, cyclophilin18, that binds CCR5 to induce activation of 
neutrophils, dendritic cells and macrophages. (B) IL-12 produced by these cells act on NK 
cells to stimulate them to produce IFN-. (C) Together, IFN- and IL-12 preferentially induce 
differentiation of Th1 cells. (D) Th1 cells secrete IFN- and, preferentially favour M1 
macrophage activation. (E) Th2 cells and Treg cells play a role in reducing inflammation 
during T. gondii infection. (F) Pregnancy is associated with an increase in progesterone 
production that stimulates NK cells and T cells to produce PIBF, which downregulates NK 
cell activity and promotes Th2 expansion. (G) Interaction of NK cells with atypical HLAs 
(HLA-C, E and G) in the maternal-fetal interface inhibits NK cell activation. (H) indolamine 
deoxygenase (IDO) induced in monocytes results in degradation of tryptophan and the 
production of kynurenine which in turn expands Treg cells. (I) Th2 cells produce IL-4 and 
IL-13 which favours M2 macrophage activation. (J) Progesterone levels are known to be 
downregulated during T. gondii infection although it is not known if this is via direct effects 
or indirectly through inflammation. The exact interaction of pregnancy and the developing 
immune response to T. gondii infection will be dependent on when during pregnancy 
infection occurs. 
 
Figure 2: Impact of T. gondii infection in pregnancy. Clinical consequences for the fetus and 
newborn and concomitant alteration to maternal immune mediators at the FMI and hormonal 
alterations (Blue: relative levels during normal pregnancy; Red arrows: effect of T. gondii 
infection on these levels during pregnancy and infection). nd: not described. 
  
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
 
 
 
 
  
